Endocrinology information for parents and visitors

Welcome to the homepage of the Endocrinology Department at Great Ormond Street Hospital (GOSH).

Issues with supply of Norditropin Flexpro pens

We have recently been made aware there are currently supply issues with Norditropin Flexpro pens which is why you are experiencing problems with the supply of your child's growth hormone. To be clear there are no safety concerns with the drug or device. This is due to problems with production within the Novo Nordisk factory.

This issue will hopefully be resolved by late February, however we will be receiving regular updates from both Novo Nordisk/ Alcura and the Department of Health who are also involved.

The consultant team have made a decision that if you still have some stock you move to alternate day dosing and when this runs out your child will have a short treatment break until supplies are stable again.

Consideration has been given to moving patients to alternative devices but this process is lengthy and not likely to happen before the Norditropin Flexpro is reinstated in late February.

We apologise for this situation and are hopeful it will be resolved soon.